Mathieu Messager - Concepedia

Author

Mathieu Messager

Hôpital Claude Huriez

Also Known As

Emilie Bruyère, M Messager, M. Messager, Mathieu Messager, Messager, Mathieu, William B. Robb

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Hôpital Claude Huriez Inserm Centre de Recherche Jean Pierre Aubert Université Lille Nord de France Université de Lille

About

Mathieu Messager is an author at Hôpital Claude Huriez specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	591
2	Gastroenterology	8	8	280
3	Cell Biology	2	2	146
4	Health Sciences	1	1	39
5	Emergency Medicine	1	1	15

Mathieu Messager

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation Guillaume Piessen, Mathieu Messager, Emmanuelle Leteurtre, Annals of Surgery	2009	314
The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma Mathieu Messager, Jérémie H. Lefèvre, Virginie Pichot-Delahaye, Annals of Surgery	2011	201
Is There a Role for Surgery for Patients with a Complete Clinical Response after Chemoradiation for Esophageal Cancer? An Intention-to-Treat Case-Control Study Guillaume Piessen, Mathieu Messager, X. Mirabel, Annals of Surgery	2013	100
Is signet-ring cell carcinoma a specific entity among gastric cancers? Thibault Voron, Mathieu Messager, Alain Duhamel, Gastric Cancer Tumor BiologyEsophageal CancerGastrointestinal OncologyMedicineGastroenterology	2015	79
Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002 Guillaume Piessen, Mathieu Messager, Karine Le Malicot, BMC Cancer	2013	75
Laparoscopic Gastric Mobilization Reduces Postoperative Mortality After Esophageal Cancer Surgery Mathieu Messager, Arnaud Pasquer, Alain Duhamel, Annals of Surgery	2015	75
Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre) Mathieu Messager, Wobbe O. de Steur, Johanna W. van Sandick, European Journal of Surgical Oncology Surgical OncologyEuropean RegistrationEsophagusGastrointestinal OncologyMedicine	2015	69
miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer Fatima Lahdaoui, Yannick Delpu, Audrey Vincent, Oncogene OncologyMucin Muc4 ExpressionPancreatic CancerMedicineCancer Cell Biology	2014	67
A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application Laurent Villeneuve, Arnaud Thivolet, Naoual Bakrin, European Journal of Surgical Oncology Surgical OncologyPeritoneal Malignancy ExtentGastrointestinal OncologyCancer DetectionMedicine	2016	64
Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer? Williams Tessier, Caroline Gronnier, Mathieu Messager, The Annals of Thoracic Surgery Surgical OncologyEsophagusEsophageal CancerGastrointestinal OncologyMedicine	2014	58

Page 1